Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

DexCom, Inc.

DXCMNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Sep 14, 2026Accepted Sep 14, 2026, 4:02 PM EDTFiling CIK 1093557Accession 0001093557-26-000173
Share

Structured filing — 4

wk-form4_1789416164.xml

Open full document ↗

Filing details

Report period
2026-09-10
Issuer
DEXCOM INC
Issuer CIK
0001093557
Trading symbol
DXCM
Rule 10b5-1 indication
Checked

Reporting owner 1

Name
Sylvain Jereme M
Reporting owner CIK
0001681267
Relationship
Officer
Officer title
EVP, Chief Financal Officer
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-09-10S · Form 43,638[F1]D83.27146,828[F2]D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
On June 10, 2026, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan.↩ 1
F2
Included in this number are 87,094 unvested restricted stock units, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 76 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.↩ 1

Signature 1

Signed
/s/ Jereme M. Sylvain
Date
2026-09-14

Company context

Current securities

Recent company filings

  1. 144 filingNov 16, 2026
  2. SCHEDULE 13G - filed by STATE STREET CORP regarding DEXCOM INCNov 10, 2026
  3. 10-Q filingOct 29, 2026
  4. Results of Operations and Financial Condition · Other EventsOct 29, 2026
  5. 144 filingSep 15, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.